相关实验视频
Updated: Jan 9, 2026

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
1.7K
长期的eplerenone治疗在周周皮质神经综合征:一个案例系列
Alba Chiara Termite1, Pasquale Viggiano1, Giacomo Boscia1
1Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro", Bari, Italy.
Case reports in ophthalmology
|December 5, 2025
概括
在12个月的时间里,eplerenone有效地降低了患有周周包皮皮皮症候群 (PPS) 的患者的胸膜厚度和视网膜液,为管理这种疾病表现出有希望的结果.
科学领域:
- 眼科医生 眼科 眼科
- 血管生物学 血管生物学
- 内分泌学 在内分泌学.
背景情况:
- 周 papillary 帕奇科罗伊德综合征 (PPS) 是一种新发现的疾病,涉及视神经的哈勒尔层的血管拥堵.
- 了解PPS病理生理学对于开发有效的治疗方法至关重要.
研究的目的:
- 评估eplerenone在管理PPS的长期有效性.
- 为了评估用eplerenone治疗的PPS患者胸膜厚度,视觉敏度和视网膜液的变化.
主要方法:
- 一项为期12个月的研究,涉及3名被诊断患有PPS的男性患者.
- 患者每天接受口服eplerenone (50毫克).
- 评估了基线和治疗后的冠状腺厚度,视力敏度和视网膜液状况.
主要成果:
- 经过12个月 (p < 0.05) 后,胆道体平均厚度 (420微米至48微米) 显著减少.
- 观察到内和下液体的几乎完全分离.
- 在治疗期间没有报告任何不良事件.
结论:
- 长期的eplerenone治疗证明了在降低冠状腺厚度和改善PPS视觉结果方面的有效性.
- 矿物甲基皮质类受体抗剂可能有助于管理帕奇科罗伊德谱系障碍.
- 对PPS的eplerenone进行进一步的研究是有必要的.
更多相关视频
相关概念视频
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Nephrotic Syndrome II : Assessment and Medical Management
184
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
184
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
426
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
426
Nephrotic Syndrome I : Introduction
470
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
470

